VJHemOnc is committed to improving our service to you

EHA 2019 | Myeloma: MAIA, COLUMBA, and CASSIOPEIA updates

VJHemOnc is committed to improving our service to you

Thierry Facon

Thierry Facon, MD, Lille University Hospital, Lille, France, gives us an update on the CASSIOPEIA study (NCT02541383), which evaluated daratumumab in transplant-eligible patients with previously untreated multiple myeloma. Speaking from the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands, Dr Facon also gives us an update on other trials, such as MAIA (NCT02252172), and COLUMBA (NCT03277105).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter